|
|
Volumn 36, Issue 6, 1999, Pages 609-620
|
|
Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: Analysis of a European, multinational, multicenter, open-label study
a
|
|
Author keywords
(1A) adrenoceptor antagonist; Benign prostatic obstruction; Lower urinary tract symptoms; Tamsulosin, 3 year follow up
|
|
Indexed keywords
ALFUZOSIN;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
DOXAZOSIN;
PLACEBO;
PRAZOSIN;
TAMSULOSIN;
TERAZOSIN;
ADULT;
AGED;
ARTICLE;
BENIGN TUMOR;
BLOOD PRESSURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EJACULATION;
EUROPE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MALE GENITAL SYSTEM DISEASE;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
PULSE RATE;
RANDOMIZED CONTROLLED TRIAL;
SYMPTOM;
TREATMENT OUTCOME;
URINARY TRACT OBSTRUCTION;
URINE FLOW RATE;
VERTIGO;
ADMINISTRATION, ORAL;
ADRENERGIC ALPHA-ANTAGONISTS;
ADULT;
AGED;
AGED, 80 AND OVER;
BLOOD PRESSURE;
HEART RATE;
HUMANS;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC HYPERPLASIA;
SULFONAMIDES;
TREATMENT OUTCOME;
URINATION;
|
|
EID: 0032699893
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000020056 Document Type: Article |
|
Times cited : (75)
|
|
References (49)
|
